{"id":1784,"text":" Phytochemical-mediated modulation of cytochrome P-450 activity may underlie many herb-drug interactions.","label":[[38,54,"Target"]],"Comments":[]}
{"id":1785,"text":"Single time-point, phenotypic metabolic ratios were used to determine whether long-term supplementation of goldenseal (Hydrastis canadensis), black cohosh (Cimicifuga racemosa), kava kava (Piper methysticum), or valerian (Valeriana officinalis) extracts affected CYP1A2, CYP2D6, CYP2E1, or CYP3A4\/5 activity.","label":[[107,140,"Herb name"],[142,176,"Herb name"],[178,207,"Herb name"],[212,244,"Herb name"],[263,269,"Target"],[271,277,"Target"],[279,285,"Target"],[290,298,"Target"]],"Comments":[]}
{"id":1786,"text":"Twelve healthy volunteers (6 females) were randomly assigned to receive goldenseal, black cohosh, kava kava, or valerian for 28 days.","label":[[0,25,"Cohort"],[7,14,"Pathology"],[29,36,"Sex"],[72,82,"Herb name"],[84,96,"Herb name"],[98,107,"Herb name"],[112,120,"Herb name"],[121,132,"Duration"]],"Comments":[]}
{"id":1787,"text":"For each subject, a 30-day washout period was interposed between each supplementation phase.","label":[],"Comments":[]}
{"id":1788,"text":"Probe drug cocktails of midazolam and caffeine, followed 24 hours later by chlorzoxazone and debrisoquine were administered before (baseline) and at the end of supplementation.","label":[[24,33,"Drug"],[38,46,"Herb name"],[75,88,"Drug"],[93,105,"Drug"]],"Comments":[]}
{"id":1789,"text":"Pre- and post-supplementation phenotypic trait measurements were determined for CYP3A4\/5, CYP1A2, CYP2E1, and CYP2D6 using 1-hydroxymidazolam\/midazolam serum ratios (1-hour sample), paraxanthine\/caffeine serum ratios (6-hour sample), 6-hydroxychlorzoxazone\/chlorzoxazone serum ratios (2-hour sample), and debrisoquine urinary recovery ratios (8-hour collection), respectively.","label":[[80,88,"Target"],[90,96,"Target"],[98,104,"Target"],[110,116,"Target"],[123,151,"Drug"],[182,203,"Herb name"],[234,270,"Drug"],[305,317,"Drug"]],"Comments":[]}
{"id":1790,"text":"The content of purported “active” phytochemicals was determined for each supplement.","label":[],"Comments":[]}
{"id":1791,"text":"Comparisons of pre- and post-supplementation phenotypic ratio means revealed significant inhibition (~40%) of CYP2D6 (difference = −0.228; 95% CI = −0.268 to −0.188) and CYP3A4\/5 (difference = −1.501; 95% CI = −1.840 to −1.163) activity for goldenseal.","label":[[110,116,"Target"],[170,178,"Target"],[241,251,"Herb name"]],"Comments":[]}
{"id":1792,"text":"Kava produced significant reductions (~40%) in CYP2E1 only (difference = −0.192; 95% CI = −0.325 to −0.060).","label":[[0,4,"Herb name"],[47,53,"Target"]],"Comments":[]}
{"id":1793,"text":"Black cohosh also exhibited statistically significant inhibition of CYP2D6 (difference = −0.046; 95% CI = −0.085 to −0.007), but the magnitude of the effect (~7%) did not appear clinically relevant.","label":[[0,12,"Herb name"],[68,74,"Target"]],"Comments":[]}
{"id":1794,"text":"No significant changes in phenotypic ratios were observed for valerian.","label":[[62,70,"Herb name"]],"Comments":[]}
{"id":1795,"text":"Botanical supplements containing goldenseal strongly inhibited CYP2D6 and CYP3A4\/5 activity in vivo, while kava inhibited CYP2E1 and black cohosh weakly inhibited CYP2D6.","label":[[33,43,"Herb name"],[63,69,"Target"],[74,82,"Target"],[107,111,"Herb name"],[122,128,"Target"],[133,145,"Herb name"],[163,169,"Target"]],"Comments":[]}
{"id":1796,"text":"Accordingly, serious adverse interactions may result from the concomitant ingestion of goldenseal supplements and drugs that are CYP2D6 and CYP3A4\/5 substrates.","label":[[87,97,"Herb name"],[129,135,"Target"],[140,148,"Target"]],"Comments":[]}
{"id":1797,"text":"Kava kava and black cohosh may interact with CYP2E1 and CYP2D6 substrates, respectively.","label":[[0,9,"Herb name"],[14,26,"Herb name"],[45,51,"Target"],[56,62,"Target"]],"Comments":[]}
{"id":1798,"text":"Valerian appears less likely to produce CYP-mediated herb-drug interactions.","label":[[0,8,"Herb name"]],"Comments":[]}
